A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: Stratification by autoantibody status in a large UK population

Genes and Immunity

Volumn 13, Issue 2, 2012, Pages 120-128

  MacKie, S L ^a   Taylor, J C ^a   Martin, S G ^a   Wordsworth, P ^b   Steer, S ^c   Wilson, A G ^d   Worthington, J ^e   Emery, P ^a   Barrett, J H ^a   Morgan, A W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

genetic susceptibility; HLA DRB1; logistic regression; rheumatoid arthritis; shared epitope

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA DRB1 ANTIGEN; RHEUMATOID FACTOR; SHARED EPITOPE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; UNITED KINGDOM;

ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENGLAND; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HLA-DRB1 CHAINS; HUMANS; MALE;

EID: 84857781570     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.60     Document Type: Article

References (64)

1. van der Woude D, Houwing-Duisternaat JJ, Toes RE, Huizinga TW, Thomson W, Worthington J et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 2009; 60: 916-923.
2. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-1213.
3. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003; 171: 538-541.
4. Stastny P. Rheumatoid arthritis: relationship with HLA-D. Am J Med 1983; 75: 9-15.
5. Thomson W, Harrison B, Ollier B, Wiles N, Payton T, Barrett J et al. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999; 42: 757-762.
6. van Gaalen FA, van AJ, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113-2121.
7. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117-1121.
8. Im CH, Kang EH, Ryu HJ, Lee JH, Lee EY, Lee YJ et al. Anti-cyclic citrullinated peptide antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared epitope status. Rheumatol Int 2009; 29: 251-256.
9. Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52: 3813-3818.
10. Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieudé P et al. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 2008; 67: 466-470.
11. Ioan-Facsinay A, Willemze A, Robinson RB, Peschken CA, Markland J, van der Woude D et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008; 58: 3000-3008.
12. Morgan AW, Thomson W, Martin SG, Carter AM, Erlich HA, Barton A, et al., Yorkshire Early Arthritis Register Consortium, UK Rheumatoid Arthritis Genetics Consortium. Reevaluation of the interaction between HLA-DRB1 SE alleles, PTPN22 and smoking in determining the susceptibility to autoantibody positive and negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 2009; 60: 2565-2576.
13. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52: 3433-3438.
14. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 2007; 56: 1446-1453.
15. Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H et al. Interaction between smoking, the shared epitope, and anticyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum 2007; 56: 1745-1753.
16. Varadé J, Loza-Santamaría E, Fernández-Arquero M, Lamas JR, de Los Angeles Figueredo M, Jover JA et al. Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis. J Rheumatol 2009; 36: 1085-1086.
17. Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC et al. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum 2010; 62: 369-377.
18. du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S et al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 2005; 52: 1063-1068.
19. Michou L, Croiseau P, Petit-Teixeira E, du Montcel ST, Lemaire I, Pierlot C et al. Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis. Arthritis Res Ther 2006; 8: R79.
20. Morgan AW, Haroon-Rashid L, Martin SG, Gooi HC, Worthington J, Thomson W et al. The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort. Arthritis Rheum 2008; 58: 1275-1283.
21. Nelson JL, Mickelson E, Masewicz S, Barrington R, Dugowson C, Koepsell Tet al. Dw14(DRB1*0404) is a Dw4-dependent risk factor for rheumatoid arthritis. Rethinking the 'shared epitope' hypothesis. Tissue Antigens 1991; 38: 145-151.
22. Wordsworth P, Pile KD, Buckely JD, Lanchbury JS, Ollier B, Lathrop M et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992; 51: 585-591.
23. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994; 37: 1166-1170.
24. McDonagh JE, Dunn A, Ollier WE, Walker DJ. Compound heterozygosity for the shared epitope and the risk and severity of rheumatoid arthritis in extended pedigrees. Br J Rheumatol 1997; 36: 322-327.
25. Meyer JM, Evans TI, Small RE, Redford TW, Han J, Singh R et al. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis. J Rheumatol 1999; 26: 1024-1034.
26. Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004; 50: 3476-3484.
27. Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008; 58: 359-369.
28. van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999; 60: 152-158.
29. Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S et al. Influence of shared epitope-negative HLADRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 2001; 44: 535-540.
30. van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE et al. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 2005; 52: 2637-2644.
31. Louzada-Junior P, Freitas MV, Oliveira RD, Deghaide NH, Conde RA, Bertolo MB et al. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies. Braz J Med Biol Res 2008; 41: 493-499.
32. Mattey DL, Dawes PT, Gonzalez-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH et al. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol 2001; 28: 232-239.
33. Shadick NA, Heller JE, Weinblatt ME, Maher NE, Cui J, Ginsburg G et al. Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1497-1502.
34. de Vries N, Tijssen H, van Riel PL, van de Putte LB. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1molecule. Arthritis Rheum 2002; 46: 921-928.
35. Barnetche T, Constantin A, Cantagrel A, Cambon-Thomsen A, Gourraud PA. New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther 2008; 10: R26.
36. Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39: 1431-1433.
37. Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, Sanchez-Mazas A et al. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Supporting online material, accessed March 2009. Hum Immunol 2008; 69: 443-464.
38. Van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008; 10: 205.
39. van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE et al. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 2007; 56: 425-432.
40. Kapitany A, Szabo Z, Lakos G, Aleksza M, Végvári A, Soós L et al. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Isr Med Assoc J 2008; 10: 32-36.
41. Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009; 68: 736-743.
42. Bonfil JJ, Dillier FL, Mercier P, Reviron D, Foti B, Sambuc R et al. A 'case control' study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol. 1999; 26: 77-84.
43. Gourraud PA, Dieude P, Boyer JF, Nogueira L, Cambon-Thomsen A, Mazières B et al. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis. Arthritis Res Ther. 2007; 9: R27.
44. Mewar D, Marinou I, Coote AL, Moore DJ, Akil M, Smillie D et al. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection. Ann Rheum Dis. 2008; 67: 980-983.
45. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmström V, Rönnelid J et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41: 1319-1324.
46. Charpin C, Balandraud B, Guis S, Roudier C, Toussirot E, Rak J et al. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Clin Exp Rheum 2008; 26: 627-631.
47. van der Woude D, Lie BA, Lundstrom E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative rheumatoid arthritis in four European populations. Arthritis Rheum 2010; 62: 1236-1245.
48. Morgan AW, Robinson JI, Conaghan PG, Martin SG, Hensor EM, Morgan MD et al. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Res Ther 2010; 12: R57.
49. Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV, Thomson W et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1529-1533.
50. van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW et al. Value of anti-modified citrullinated vimentin and second-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum 2009; 60: 2232-2241.
51. Bos WH, Ursum J, de Vries N, Bartelds GM, Wolbink GJ, Nurmohamed MT et al. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels. Ann Rheum Dis. 2008; 67: 1347-1350.
52. Karlson EW, Chibnik LB, Cui J, Plenge RM, Glass RJ, Maher NE et al. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis. 2008; 67: 358-363.
53. de Rooy DPC, van der Linden MPM, Knevel R, Huizinga TWJ, van der Helm-van Mil AHM. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 2011; 50: 93-100.
54. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet. 1989; 45: 541-546.
55. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
56. Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J Rheumatol 2002; 29: 1821-1826.
57. Kim TG, Choi HB, Park SH, Kim HY, Han H. DQCAR 113 and DQCAR 115 in combination with HLA-DRB1 alleles are significant markers of susceptibility to rheumatoid arthritis in the Korean population. Tissue Antigens 1999; 54: 552-559.
58. Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T et al. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol 2007; 25: 219-224.
59. Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW et al. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 2005; 52: 3058-3062.
60. Vignal C, Bansal AT, Balding DJ, Binks MH, Dickson MC, Montgomery DS et al. Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci. Arthritis Rheum 2009; 60: 53-62.
61. Lundstrom E, Kallberg H, Smolnikova M, Ding B, Rönnelid J, Alfredsson L et al. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative rheumatoid arthritis. Arthritis Rheum. 2009; 60: 924-930.
62. Ding B, Padyukov L, Lundstrom E, Seielstad M, Plenge RM, Oksenberg JR et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anticitrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009; 60: 30-38.
63. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
64. Macgregor AJ, Bamber S, Silman AJ. A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol 1994; 21: 1420-1426.